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Abstract
Background: Allergies represent the most prevalent non infective diseases worldwide. Approaching IgE-mediated
sensitizations improved much by adopting allergenic molecules instead of extracts, and by using the micro-technology for
multiplex testing.
Objective and Methods: To provide a proof-of-concept that a flow cytometric bead array is a feasible mean for the
detection of specific IgE reactivity to allergenic molecules in a multiplex-like way. A flow cytometry Allergenic Molecule-
based micro-bead Array system (ABA) was set by coupling allergenic molecules with commercially available micro-beads.
Allergen specific polyclonal and monoclonal antibodies, as well as samples from 167 allergic patients, characterized by
means of the ISAC microarray system, were used as means to show the feasibility of the ABA. Three hundred and thirty-six
sera were tested for 1 or more of the 16 selected allergens, for a total number of 1,519 tests on each of the two systems.
Results: Successful coupling was initially verified by detecting the binding of rabbit polyclonal IgG, mouse monoclonal, and
pooled human IgE toward three allergens, namely nDer s 1, nPen m 1, and nPru p 3. The ABA assay showed to detect IgE to
nAct d 1, nAct d 11, rAln g 1, nAmb a 1, nArt v 3, rBet v 1, rCor a 1, nCup a 1, nDer p 1, nDer s 1, rHev b 5, nOle e 1, rPar j 2,
nPen m 1, rPhl p 1, and nPru p 3. Results obtained by ABA IgE testing were highly correlated to ISAC testing (r=0.87,
p,0.0001). No unspecific binding was recorded because of high total IgE values.
Conclusion: The ABA assay represents a useful and flexible method for multiplex IgE detection using allergenic molecules.
As also shown by our initial experiments with monoclonals and polyclonals, ABA is suitable for detecting other human and
non-human immunoglobulins.
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Introduction
There is a growing body of evidence that IgE-mediated allergic
diseases have increased over the last 40 years to the point of
becoming the most prevalent diseases in the Western world [1,2].
The diagnostic work-up in allergic diseases is largely based on the
use of extracts for both skin tests and in vitro IgE testing [3,4]. A
number of pitfalls affect the reliability of these diagnostic
approaches, due to the poor quality of the extracts, their unknown
component content and sometimes the presence of unwanted
contaminants [5].
During the last decades the understanding about allergenic
molecules has steadily increased year by year, thus resulting in a
remarkable expansion in the identification, characterization and
production of allergens, either natural or recombinant (http://
www.allergome.org/script/statistic.php).
During the last 10 years, the use of allergenic molecules
immobilized on microarrays has been the most fascinating novelty
for in vitro specific IgE detection [6], allowing at the same time both
a higher definition of the patient’s IgE sensitization profile and a
broader evaluation of IgE reactivity in an unprecedented
epidemiological study scale [7]. In fact, besides the use of micro-
technology for developing the novel IgE detection method,
microarrays like the ISAC (Phadia Multiplexing Diagnostics,
PMD, Vienna, Austria) used in the study of Scala et al. [7] bear
the intrinsic concept of multiplex testing, where multiplexing
means testing a single specimen of the serum sample obtaining
hundreds of results at once [8,9].
A major criticism has been raised toward this multiplexing
approach as it is felt to be too rigid in the allergen selection. It
seemed to us then that there could be the need for a more flexible
but anyhow multiplexed immunoassay platform, allowing the
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controls) or for introducing customized target molecules (e.g. new
allergenic molecules).
A flow cytometric bead array (CBA) was developed to detect
soluble factors, like cytokines or mediators, released in vivo or in vitro
during spontaneous or experimentally-induced immune responses
[10–12]. CBA, in the form of naked fluorescent micro-beads
named BD CBA Functional Beads by the producer, can also be
customized to detect specific antibodies [10,11], although not
many reports on this specific application are found in the literature
[13]. The peculiarity of the BD CBA Functional Beads compared
to other micro-bead-based systems [14–16] is the use of the flow
cytometer, an instrument currently used in almost all large routine
and research laboratories.
Drawing inspiration from the early reports of the method
developer [10,11] and the following applications [13], we sought
to verify whether allergenic molecules conjugated to the BD CBA
Functional Beads could be also useful for specific IgE detection,
creating a ‘‘flexible’’ microarray for detecting IgE in human sera.
After a series of experiments to set up the BD CBA Functional
Beads to meet the need of measuring the less represented
immunoglobulin isotype in human serum, we succeeded in
detecting specific IgE to allergenic molecules with this new
method, named Allergen micro-Bead Array (ABA), obtaining
comparable results as from the currently available ISAC
microarray assay. The use of the ISAC microarray IgE detection
system was decided to be the reference system because of its
similar micro-dimension reaction kinetic, and because it is the only
multiplexing test using allergenic molecules instead of extracts,
bearing all allergenic molecules used in the present study.
Methods
Allergen micro-Bead Array - Conjugation Procedure
Allergenic molecules selected for micro-beads conjugation,
derived from animal, pollen, and fruit allergenic sources were
used. For the first set of experiments, lyophilized purified natural
(n) Der s 1, a group 1 mite allergen from Dermatophagoides siboney,
was provided by Biocen [17] (Havana, Cuba), nPen m 1, a
tropomyosin from a shrimp species (Penaeus monodon) was
purchased from BIAL-Aristegui (Bilbao, Spain), and nPru p 3, a
lipid transfer protein (LTP), was purified from peaches (Prunus
persica) as previously reported [18]. nPru p 3 preparation
immobilized on ISAC was not the same used for micro-bead
conjugation.
For the second part of the study, using a broader panel of
molecules including the three mentioned above, the following
additional thirteen allergens were considered: nAct d 1, a cystein
protease, and nAct d 11, a ripening-related protein, recently
reported as allergen, both purified from green kiwifruit (Actinidia
deliciosa) [19,20], nAmb a 1, purified from ragweed pollen (Ambrosia
artemisiifolia) as reported in literature with minor modifications
[21]; nArt v 3, a LTP from mugwort pollen (Artemisia vulgaris),
purified recombinant (r) Aln g 1, rBet v 1, and rCor a 1, marker
allergens from alder pollen (Alnus glutinosa), birch pollen (Betula
verrucosa), hazel tree pollen (Corylus avellana), respectively (kindly
given by Christian Harwanegg, VBC-Genomics, Vienna, Austria);
nCup a 1, the Arizona cypress pollen allergen (Cupressus arizonica),
nOle e 1, an olive tree pollen allergen (Olea europaea), rPar j 2, the
parietaria pollen allergen (Parietaria judaica), and rPhl p 1, a grass
pollen allergen (Phleum pratense) (BIAL-Aristegui); nDer p 1, a house
dust mite major allergen (Dermatophagoides pteronyssinus) (Indoor
Biotechnologies, Cardiff, UK); rHev b 5, a marker of natural latex
allergy (Hevea brasiliensis) (Biomay, Vienna, Austria). Further details
on single molecule characteristics are available on the Allergome
web site (www.allergome.org) [22]. All allergens were reconstituted
with PBS at a concentration of 1 mg/ml and stored at 220uC
until used for conjugation.
The color-coded polystyrene micro-beads (Becton Dickinson,
New Jersey, USA) of distinct and non-overlapping fluorescence
emission intensities [10,11] were used and covalently coupled with
allergenic molecules using the suggested sulfosuccinimidyl 4-N-
maleimidomethyl cyclohexane 1-carboxylate (sulfo-SMCC) chem-
istry. Sulfo-SMCC contains N-hydroxysuccinimide (NHS) ester
and maleimide groups. NHS esters react with primary amines at
pH 7–9 to form amide bonds, while maleimide groups react with
sulfhydryl groups at pH 6.5–7.5 forming stable thioether bonds.
The micro-beads herein used colored with a water-insoluble dye,
excitable by a 488-nm laser source, with emission at 576 nm
(Becton Dickinson) were the same used in other commercially
available ready-made CBA assays. The unique difference is that
the micro-beads used in the present study were un-conjugated.
Thirty different micro-beads having a different mixture of APC-A
and APC-Cy7 fluorescence are currently available from the
manufacturer [10,11].
The conjugation procedure consisted of four steps: micro-bead
preparation, protein modification, buffer exchange, and protein
conjugation.
Micro-bead preparation. The BD CBA Functional Beads
(Becton Dickinson) were used. Selected micro-beads chosen for
conjugation were vortexed vigorously for 30 seconds; 75 mlo f
micro-beads were taken for 500 test reactions; 1 M 1.9 ml
dithiothreitol stored at 220uC (Pierce, Rockford, USA) were
added to a micro-centrifuge tube containing the micro-beads and
vortexed again for 5 seconds. The mix was incubated on an orbital
shaker for 1 h at R.T. in the dark. After incubation, 1 ml of
coupling buffer (Becton Dickinson) was added and vortexed for
5 seconds. Afterwards, the micro-beads were centrifuged at 9006
g for 3 minutes. Afterwards, supernatant removal micro-beads
were washed three times and the pellet re-suspended in 20 mlo f
coupling buffer.
Allergenic molecule activation. Ninety ml of selected
allergens at a concentration of 1 mg/ml were used for preparing
500 tests. Sulfo-SMCC (Pierce) stock solution (2 mg/ml water
solution) was prepared immediately before use, and 2 ml were
added to the protein preparation. The mixture was incubated on
an orbital shaker for 1 h at R.T. in the dark.
Buffer exchange to remove free components. The Bio-
Rad Spin Columns (Bio-Rad, Milan, Italy) were washed with
coupling buffer twice and then placed in a tube and centrifuged for
2 minutes at 1,0006 g. After centrifugation, the columns were
placed in a new tube and the entire volume of protein/sulfo-
SMCC solution was transferred to the spin columns and
centrifuged again at 1,0006g for 2 minutes.
Allergenic molecule conjugation. Activated proteins in the
eluate were transferred into the tube containing the previously
prepared functional micro-beads and vortexed for 5 seconds.
Proteins and micro-beads were incubated for 1 h at R.T. on an
orbital shaker in the dark. Two ml of N-ethylmaleimide (2 mg/ml
in DMSO, Pierce) were added to the tube containing functional
micro-beads and activated protein, vortexed for 5 seconds and
incubated for 15 minutes on an orbital shaker. After incubation,
1 ml of the storage buffer was added into the tube and the micro-
beads were centrifuged for 3 minutes at 9006 g. Washes with
storage buffer were repeated three times. Afterwards, the micro-
bead pellet, re-suspended in 0.5 ml of storage buffer, was stored at
+4uC, at a concentration of 6610
6 micro-beads/ml.
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Monoclonal and polyclonal primary non-human
antibodies. To verify the coupling of selected allergens,
specific mouse monoclonal (MoAb) and rabbit polyclonal (PoAb)
antibodies were used as probes. To detect nDer s 1 onto the micro-
beads, two different MoAbs were used, an IgG1 isotype (4E10/
E10) and an IgG2b isotype (5F7/H8F2) (Biocen) [17]. For
detecting nPen m 1 conjugation to the micro-beads an anti-
shrimp tropomyosin PoAb was used (BIAL-Aristegui). nPru p 3
coupling to the micro-beads was assessed using an anti-Pru p 3
MoAb (kindly given by Domingo Barber, Alk-Abello ´, Madrid,
Spain) [23] and two different anti-Pru p 3 PoAb, the first kindly
provided by Alk-Abello ´ [23] and the second purchased from
BIAL-Aristegui. Isotype matched mouse MoAbs to bovine serum
albumin and fish parvalbumin and rabbit PoAbs against the same
proteins were tested on the three allergen-conjugated beads used
for specificity control purposes in preliminary experiments.
Human sera. Initially, sera from a total of 167 clinically
allergic subjects presenting for a consult at the Center for
Molecular Allergology (IDI-IRCCS, Rome, Italy) were selected
after testing on the ISAC system, bearing recombinant and natural
allergens immobilized in triplicate on a glass slide [9], and
following the reported methodology [7]. Samples were selected on
the basis of their reactivity to the above three candidate allergens
as detected either by the ISAC 89 (VBC-Genomics) or the ISAC
103 microarray systems (PMD). ISAC IgE values are expressed in
kUa/l. Selected subjects for the Der s 1 ABA testing reported a
reliable history of respiratory symptoms of rhinitis and/or asthma
suggesting mite allergy and all had IgE positive result using the
Dermatophagoides pteronyssinus ImmunoCAP test (Phadia, Uppsala,
Sweden). A reliable clinical history of food reactions (recent
generalized reactions or anaphylaxis) or a positive double blind
food challenge test for peach or shrimps, and a positive
ImmunoCAP IgE testing for Pru p 3 or Pen a 1, peach LTP
and shrimp tropomyosin respectively, were the basis for selecting
patients for Pru p 3 and Pen m 1 ABA testing. All subjects were
recruited for previously published collaborative studies within our
research Center. Allergic control subjects did not report symptoms
in relation to exposure to any of the three allergens and had
negative allergy in vitro tests.
Human sera to create pools were selected to define the ABA
experimental conditions. In order to obtain the highest IgE signal
after ABA testing, three distinct pools of sera were set. Sera from
twelve patients having nDer s 1 specific IgE on ISAC testing,
ranging between 8 and 139 kUa/l were mixed together creating
the Der s 1 sera pool. The 12 samples were also reactive to other
ISAC tested group 1 mite allergens, namely nDer p 1 or nDer f 1.
Eighteen nPru p 3 positive patients (ISAC IgE values ranged
between 5.4 and 59.29 kUa/l), and 21 nPen m 1 positive patients
(ISAC IgE values ranging between 5.07 and 92.77 kUa/l) were
selected for the Pru p 3 and the Pen m 1 sera pools, respectively. In
all three cases, although sera were selected on the basis of one of
the three specificities - but then used for detecting coupled
molecules and ABA optimization - the other two specificities could
be present at a lower IgE level, and not avoided on purpose. Three
serum samples were selected from patients with one of the three
specificities included in our study and not the other two. A forth
one had no ISAC detectable nPru p 3 specific IgE. The selection
was made in the attempt to mimic the use of discrete antigen
specific non-human antibodies, and setting the multiplex approach
to verify ABA specificity. Not relevant, but anyway tested
allergenic molecules in the same tube, acted as negative controls
when the targeted one was tested.
All other human sera used in the study were tested as single
non-pooled samples. The number of samples is reported in the
Result section for each allergen specificity and detailed in Table
S1. Subjects selected for this part of the study had, in case of food
allergens, a reliable clinical history or a positive specific food
challenge for the related allergenic source, and a reliable clinical
history of respiratory symptoms for the remaining allergens.
Total IgE were measured using the ImmunoCAP system
(Phadia). As the assay defines IgE concentrations in a range
between 1 and 2000 IU/l, sera having very high total IgE levels
(.2,000 IU/l) were tested diluted 2 or higher folds in order to get
the correct estimation of their total IgE values.
Oral informed consent for blood sampling was obtained from
patients or caregivers during the allergy consult as a normal
routine procedure during the allergic disease diagnostic work-up.
This procedure was approved by our Institutional ethical
committee as it is part of a routine procedure where no consent
is required by law. Due to the limited amount of serum to be used
in the test, no additional blood drawing was necessary. The study
was approved by our Institutional ethical committee, at the Istituto
Dermopatico dell’Immacolata, Rome, Italy. Informed signed
consent was obtained by patients and caregivers when the serum
samples were used for the initial part of our study where the new
system was set up.
Multiplex testing procedure
One ml of conjugated micro-beads was used for each test, for
each specific allergen. The micro-beads, washed with 0.5 ml of
washing buffer as provided by the manufacturer, were centrifuged
for 5 minutes at 2006 g. After removing the supernatant, the
micro-beads were re-suspended in capture micro-bead diluent for
serum and plasma to a final volume of 50 ml/test, then vortexed
and incubated for 15 minutes in the dark at R.T. Fifty ml of micro-
bead mix was combined with 50 ml of the biological sample to be
tested, being either non-human or human sera, vortexed, and then
incubated for 1 hour at R.T. in the dark. PoAbs, MoAbs, human
serum samples were used in each given experiment as reported in
the Results section. Tested samples were then washed by adding
0.5 ml of washing buffer and then centrifuged for 5 minutes at
2006g. The supernatant was aspirated and the pellet re-suspended
in 100 ml capture micro-bead diluent for serum and plasma
(Becton Dickinson), then 50 ml of the detection diluent containing
phycoerythrin- (PE; 5–20 ml) or fluorescein isothiocyanate-conju-
gated secondary antibody (FITC; 20 ml) were added to each tube,
vortexed, and then incubated for 1 h at room temperature in the
dark. Secondary antibodies used in our ABA assay were as follows:
a FITC conjugated goat anti-rabbit IgG (GenWay Biotech Inc.,
San Diego, USA) was used for rabbit primary PoAbs (10 ml for
each sample); MoAbs were detected using 5 ml of PE-conjugated
goat anti-mouse (Dako Cytomation, Milan, Italy); human IgE
were detected using 20 ml of PE-conjugated anti-human IgE
(Becton Dickinson). The detection diluent was added to all
secondary antibodies to reach the final volume of 50 ml. Samples
were then washed once as described above and finally re-
suspended in 300 ml of washing buffer.
Specimens were analyzed according with the CBA assay for
cytokine detection [10,11] by using the FACSAria flow cytometer.
FACSDiva software (Becton Dickinson) was used for data
capturing and a first analysis. Briefly, cytometer setup micro-
beads adsorbed with FITC- or PE-positive control detector
reagents were used to adjust the side scatter (SSC), the forward
scatter (FSC), and the FL1, FL2, FL3, and FL4 photomultiplier
tube settings so that each of the four micro-bead types clustered
within the first decade of fluorescence. The analysis of a human
Allergen Micro-Bead Array for IgE Detection
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negative on the basis of a negative allergy clinical history and
repeated ISAC negative testing, was used to verify that photo-
multiplier tube settings and compensation were correct. Upon
analysis of raw data, the median fluorescence intensity (MFI) of
each micro-bead cluster was quantified.
Five tubes labelled A9, PE-F1, F1, F9 and A1 were prepared.
After vortexing, 200 ml of washing buffer was added to each tube
followed by 25 ml of the corresponding setup micro-beads. The
following parameters were edited: FSC-A, FSC-W, SSC-A, SSC-
W, PE-A, APC-A and APC-Cy7-Then, the following plots were
created on a global worksheet : FSC-A/SSC-A dot plot, APC/
APC-Cy7 dot plot and a PE histogram. The FSC-A and SSC-A
were set to log and a statistic view was created showing the FSC-A
and the SSC-A means. Measurements were performed counting at
least 500 events for each analysis. The FSC and SSC thresholds
were adjusted using the mean channel as a guideline. In the FSC-
A vs SSC-A dot plot a region was created that includes the singlet
population of micro-beads. The statistics view was edited to
display the PE, FITC, APC and APC-Cy7 median fluorescence
values. Through the singlet gate, the A9 setup micro-beads were
run and the voltage of APC and APC-Cy7 were adjusted until
obtaining a 160,00062,000 mean for each parameter. Through
the singlet gate the PE-F1 tube was run and the PE voltage was
adjusted until a mean value of 6565 was reached.
ABA-measured IgE values were expressed as MFI as given by
the final readout of the cytometer. No standard curves, as reported
in other studies [24], were created to normalize MFI and obtain
ABA IgE semi-quantitative values as for the ISAC system. A blank
reading for each run, made with conjugated micro-beads and
micro-beads plus serum without secondary antibody to measure
background fluorescence, was performed always with comparable
very low range fluorescence results (data not shown). As a totally
negative MFI was seldom recorded for allergic sera when the PE-
anti-IgE was added (47 out of 1,519 determinations, 3.1%, Table
S1), we tentatively set a negative cut off point for the new detection
system at a value being the mean plus three standard deviations of
the ABA IgE values of all the ISAC IgE negative tests used in the
present study, plus all the conjugated micro-bead fluorescence
values obtained before serum testing and evaluated at every ABA
run (example given in Figures 1, panel A and Figure 2, panel A).
Overall 799 ISAC IgE negative results and 238 blank micro-beads
values were combined, resulting in a negative cut off value equal to
200 MFI. The cut off value was used for the IgE data analysis of
the last set of 336 sera.
Data management and Statistics
Demographic and clinical data were recorded for all patients at
admission by using the InterAll software, a customized allergy
electronic record for diagnostic and clinical data storing (version
3.0, Allergy Data Laboratories s.c., Latina, Italy). All laboratory
data obtained in the present study along with all ISAC and ABA
testing results were stored in the patients’ personal records and
analyzed.
Graphpad Prism version 5.02 was used for statistics and graphs
(Graphpad Software Inc., La Jolla, CA, USA). The frequencies of
events were compared by using the Fisher’s exact test and the x
2
test was used for the two by two contingency tables. The non-
parametric Spearman correlation coefficient (r) was used to
compare the IgE values obtained by the two testing systems. All
tests were used with two-sided options and the statistically
significant level was set at a p value,0.05.
Results
Allergenic molecules conjugation evaluated using
specific polyclonal and monoclonal antibodies
To begin validation of the ABA system, the proof of a successful
allergen conjugation on the blank micro-beads was searched in
three independent experiments. The recognition of nDer s 1, nPen
m 1 and nPru p 3 by specific non-human antibodies was tested
with both a singleplex and a multiplex approach. In the singleplex
assays, every molecule coupled with the micro-beads was tested
with its specific antibody. In the multiplex approach, the three
molecules, coupled with their respective micro-beads, were tested
simultaneously with each of the antibodies to check any reciprocal
interference.
Two different MoAbs to nDer s 1 were tested; the 4E10/E10
showed that the allergen was specifically coupled with the micro-
bead, with a higher performance when compared to the MoAb
5F7/H8F2 (Figure 1, panel A). nPen m 1 conjugation, tested using
the tropomyosin specific PoAb, produced very good results
showing a successful conjugation of the molecule (Figure 1, panel
A). nPru p 3 conjugation to the micro-beads was evaluated by
means of one MoAb and two different PoAbs in independent
experiments. As shown in Figure 1, panel A, all the anti-Pru p 3
antibodies showed an overall good recognition of the conjugated
nPru p 3, though the two PoAbs performed more homogeneously
in terms of a narrower range of fluorescence emission when
compared to the MoAb, anyway providing the proof of a proper
conjugation of the molecule on the blank micro-bead.
In order to exclude a possible interference, the three different
micro-beads conjugated with nDer s1, nPen m 1, nPru p 3, were
mixed in the same tube to be tested. The best performing
antibodies among those reported above were used, namely the
anti-Der s 1 MoAb, clone 4E10/E10, the anti-tropomyosin and
the anti-Pru p 3 PoAb supplied by Alk-Abello ´. Figure 1, panel B,
shows the selective recognition of the three allergens by the
respective antibody in the multiplexing approach and the absence
of interference among different allergen conjugated micro-beads.
Reproducibility of the results obtained by testing the selected
polyclonals anti-tropomyosin and anti-Pru p 3, and the monoclo-
nal anti-Der s 1 was explored in three different experiments. All
positive results were reproduced but a very high coefficient of
variability was obtained (approx 50% considering all the
experiments together; data not shown). The same antibodies were
then used to create dilution curves in separate experiments.
Graphs, as reported in Figure S1, show acceptable dilution curves,
but also a great variability in the allergen/antibody performances
in the ABA system by the three combined antigen/antibody
preparations.
None of the control MoAbs or PoAbs produced any unspecific
binding with the three allergen-conjugated beads, since the
recorded fluorescence signal was always within the lowest
background range (data not shown).
Allergenic molecule conjugation and reactivity evaluated
using specific pooled human IgE
To validate data obtained by non-human antibodies and obtain
the first proof of feasibility of the new testing, IgE recognitions of
the three molecules were analysed. Pooled sera from individual
donors reactive to nDer s 1, nPen m 1 and nPru p 3 were used in
three independent experiments. As for non-human antibodies, the
reactivity profiles of the pooled sera were evaluated both in ABA
singleplex and multiplex. Singleplex results, obtained by testing the
single micro-bead with the specific serum pool, reflected the
specific IgE recognition pattern obtained using the ISAC system
Allergen Micro-Bead Array for IgE Detection
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looked much alike those obtained by non-human antibody testing
as reported above in Figure 1.
When the three micro-beads were tested together, they
produced the following results (Figure 2, panel B): the Der s 1-
selected pooled sera, known to have ISAC detected IgE to nPen m
1 and nPru p 3, showed specific IgE reactivity to all the molecules
tested in the ABA multiplexed array. The nPen m 1-selected
specific pooled sera gave just one strong signal on nPen m 1, but to
a minor extent recognized also nDer s 1 and nPru p 3, comparably
to results previously obtained using the ISAC test. In the case of
the LTP-selected pooled sera, nPru p 3 produced a strong positive
signal, whilst a slight IgE reactivity was observed for nDer s 1, and
none to nPen m 1, in agreement with ISAC testing.
Additional experiments according to this validation approach
included the evaluation of three mono-reactive patients to either
nDer s 1, or to nPen m 1, or to nPru p 3, and an additional
individual having IgE to both nDer s 1 and nPen m 1. As shown in
Figure 3, all the known reactivities were confirmed, thus indicating
the specificity of IgE recognition using the ABA test in perfect
agreement with ISAC IgE testing.
ABA versus ISAC Comparative IgE testing
One hundred and thirty-seven allergic individuals were selected
on the basis of their ISAC IgE reactivity to one of the three
allergens of our study and not to the other two. Twenty-nine nDer
s 1 positive patients (16 males, median age 13 years, range 2–39
years), 28 nPen m 1 positive (16 males, median age 14 years, range
3–60 years), and 55 nPru p 3 positive (25 males, median age 28
years, range 9–69 years) were selected. Twenty-five allergic
subjects (18 male, median age 19, range 2–49 years old), without
any of the three above positive IgE determinations on ISAC acted
as negative controls. Without a set cut off value for the ABA IgE
detection system, any value above the no fluorescence signal was
considered as positive.
When comparing ABA IgE reactivity to the ISAC IgE testing in
the 137 samples (411 determinations), a statistically significant high
correlation was found (r=0.87, CI 0.84–0.89; p,0.0001)
(Figure 4, panel A), confirmed by the contingency table evaluation
(p,0.0001). Results were anyhow scattered across a quite large
area and some ISAC positive/ABA negative results were evident
rather than the opposite. When a discrete allergen-driven analysis
was performed, all samples tested for nDer s 1 (Figure 4, panel B)
and nPen m 1 (Figure 4, panel C) were ABA IgE positive, with
very high r values, equal to 0.98 (CI 0.92–0.99; p,0.0001) and
0.988 (CI 0.98–0.99; p,0.0001), respectively. When comparing
nPru p 3 reactivity (Figure 4, panel D), 36 patients were ISAC/
ABA double positive, whilst 19 turned out to be negative after
ABA test, but ISAC positive, and 1 case was ABA positive, but
lacking ISAC IgE reactivity. Statistics were as follows: r=0.7 (C.I.
0.60–0.78), Fisher’s exact test p,0.001. All 25 control allergic
subjects not sensitized to nDer s 1, nPen m 1 and nPru p 3 were
negative for ABA IgE testing on the three candidate molecules.
ABA multiplex IgE testing on additional allergenic
molecules
To show the feasibility of the system as a flexible multiplex array
and to explore if we introduced any bias in previous experiments
due to the limited number of sera and allergens, we additionally
tested 336 sera from allergic patients, 171 females (50.9%), median
age 27 years, range 2–80 years, 70 of them were younger than 12
years old, 17 in pre-school age. Full demographics are reported in
Table S1. IgE were assessed using 16 allergenic molecules, namely
nAct d 1, nAct d 11, rAln g 1, nAmb a 1, nArt v 3, rBet v 1, rCor a
1, nCup a 1, nDer p 1, nDer s 1, rHev b 5, nOle e 1, rPar j 2, nPen
m 1, rPhl p 1, and nPru p 3. Results for each allergen are reported
in Table S1 and Figure 5, 6, 7, 8, as indicated in the legends. Each
sample was selected on the basis of the ISAC IgE positive results to
one of the above allergen specificities, but other positive and
negative ISAC IgE results were considered and tested as well.
Before each ABA IgE testing session selected allergen micro-beads
bearing the leading specificity of each sample included in our study
were mixed in all tubes. Thus a different set of allergens was used
in each session, always including between 1 and 11 different
allergens, as detailed in Table S1.
When comparing all ABA/ISAC results obtained after a total of
1,519 unique determinations on each system, a high correlation of
measured IgE values (r=0.86, C.I. 0.84–0.87; p,0.0001) and a
very high agreement of positive and negative tests (x
2 1096.1,
p,0.0001) were found (Figure 5). Discrete allergen specificity was
then analyzed to see whether different behaviors of the ABA IgE
testing system could be related to the different molecules used for
the test. All graphical representations and statistical evaluations are
exhibited for each allergen in the respective panels in Figures 5, 6,
7 and 8, as detailed by the letters in the Figure legends.
Consecutive letter assignment to each allergen panel was made
on purpose across the four Figures to recall result type continuity.
The number of single observations per allergen ranged between
n=63 (nAmb a 1, Figure 6, panel E and Table S1) and n=191
(nPru p 3, Figure 8, panel Q and Table S1). Correlation values
were all statistically significant at the same level (p,0.0001) with
the Spearman r coefficient ranging between 0.46 (rCor a 1,
Figure 7, panel H) and 0.91 (nCup a 1, Figure 7, panel I). The best
performance rates, considering the concordance of positive and
negative tests, were recorded for rAln g 1, nAmb a 1, rBet v 1,
rCor a 1, nDer p 1, rHev b 5, rPar j 2, and nPen m 1 allergens.
The allergen where the highest ABA/ISAC discrepancies were
recorded was nDer s 1 (Figure 7, panel K), whereas rBet v 1
(Figure 6, panel G) had no discrepancies.
The nDer s 1 ABA IgE results (Figure 7, panel K) quite often
showed to be slightly above the in-house defined cut off value
compared to the negative value obtained with the same
preparation immobilized on the ISAC microarray, whereas the
opposite discrepancy was recorded again for the nPru p 3 (Figure 8,
panel Q), with 13 positive IgE values on the ISAC system not
replicated by the ABA assay. It is important to note that the same
nDer s 1 preparation was used in the two testing system, whereas
the two preparations on ABA and ISAC were from different
providers.
Figure 1. Detection of allergen conjugation on micro-beads using mouse monoclonal and rabbit polyclonal antibodies. Panel A: Each
antibody preparation was tested on the respective allergen-coupled micro-bead. The other two micro-beads were not in the tube. NP: Not performed
in this singlepex testing. * Values are expressed as Median Fluorescence Intensity [MFI]. Upper right corner: an example of blank fluorescence reading
of the three conjugated micro-beads without serum. Panel B: Antibodies selected on the basis of the findings reported in panel A were tested on the
three allergen-coupled micro-beads, all found in the same testing tube. * Values are expressed as Median Fluorescence Intensity [MFI]. Upper right
corner: an example of micro-bead fluorescence scatter plot and micro-bead clusters.
doi:10.1371/journal.pone.0035697.g001
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PLoS ONE | www.plosone.org 6 April 2012 | Volume 7 | Issue 4 | e35697Figure 2. Detection of allergen conjugation on micro-beads using human pooled sera containing specific IgE. Selected pooled human
sera with IgE specific for the three candidate allergens were tested to verify that allergen coupling was acceptable also for human immunoglobulin
determination and to estimate interference among different allergen-conjugated micro-beads. Panel A: Each serum pool was tested on the respective
allergen-coupled micro-bead. The other two micro-beads were not in the tube. NP: Not performed in this singlepex testing. u Values are expressed as
kU/l. * Values are expressed as Median Fluorescence Intensity [MFI]. Upper right corner: an example of blank fluorescence reading of conjugated
micro-beads without serum. Panel B: Serum pools were tested on the three allergen-coupled micro-beads present in the same tube. u Values are
expressed as kU/l. * Values are expressed as Median Fluorescence Intensity [MFI]. Upper right corner: an example of micro-bead fluorescence clusters.
doi:10.1371/journal.pone.0035697.g002
Allergen Micro-Bead Array for IgE Detection
PLoS ONE | www.plosone.org 7 April 2012 | Volume 7 | Issue 4 | e35697To evaluate the interference of high total IgE values on the ABA
IgE detection system, 117 samples having estimated total IgE
values were selected (Table S1). Two subsets were created where
the total IgE value was either below or above 1,000 IU/l. The first
subset of 54 samples had total IgE values within the range of 4–
924 IU/l, whereas 63 samples in the second subset had total IgE
within the range of 1,087–39,038 IU/l. The number of positive
ABA IgE tests (.200 MFI), when the ISAC IgE testing was
negative, it was compared between the two subsets, taking into
account the number of negative ISAC tests in the low and high
subgroups, equal to 126 and 351, respectively. Twelve samples
(9.52%) in the subset with total IgE,1,000 IU/l had ABA IgE
values above the cut off, whereas 35 (9.97%) of the high/very high
total IgE samples were above the ABA cut off value. The two
frequencies were not statically different when evaluated with the
Fisher’s exact test.
Overall, Table S1 fully reports on single patient ABA IgE testing
data and recorded profiles, showing the configurable aspect of the
new assay. In order to show how a real ABA testing report from
the cytometer looked like, six examples of ABA IgE testing were
selected among those displayed in Table S1 (marked in blue) and
shown in Figure 9. Eleven different micro-beads were tested in the
same tube in each run for each sample. Examples were selected on
purpose among the samples with high total IgE, values ranging
between 1,220 and 23,540 IU/l. All IgE positive and negative
ABA results matched the ISAC results. Reports clearly showed
Figure 3. Testing human sera containing specific IgE on allergen conjugated micro-beads. Three human individual serum samples
(49812, 49141, 33020), each of them known to have specific IgE to one allergen and not to the others were tested on the three micro-beads present
in the same tube. Serum 31851 was from a subject recognizing nDer s 1 and nPen m 1, but not nPru p 3. A non allergic donor was used for control
purposes. # Serum sample numbers; u Values are expressed as kU/l; * Values are expressed as Median Fluorescence Intensity [MFI]. Upper right
corner: an example of micro-bead fluorescence clusters.
doi:10.1371/journal.pone.0035697.g003
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PLoS ONE | www.plosone.org 8 April 2012 | Volume 7 | Issue 4 | e35697how the scatter plot of each micro-bead discriminated the used
ones by their individual fluorescence, how the micro-bead count
and fluorescence intensity were displayed and measured, and the
calculation to obtain the median fluorescence value of each tested
allergen.
To evaluate the reproducibility of the IgE determinations
performed with the ABA system, we selected 114 consecutive
samples from subjects as in the Table S1, obtaining 283 paired
determinations, and all performed in two separated ABA runs.
The experiments used 15 of 16 allergens under study. Not all
allergens and subjects were tested the same number of time and
aggregated data are provided in terms of IgE value correlation and
concordance. Supplementary Figure S2 shows the correlation
graph and the statistical evaluations are reported in its legend.
Figure 4. ABA versus ISAC correlation results on 137 serum samples selected on the basis of nDer s 1, nPen m 1, and nPru p 3
mutually exclusive IgE positivity are reported. Panel A: All 411 IgE values, obtained by testing the three allergens; Panel B: 137 IgE results
obtained on nDer s 1 allergen; Panel C: 137 IgE results obtained on nPen m 1 allergen; Panel D: 137 IgE results obtained on nPru p 3 allergen. For
graphical visualization needs on log scales, zero values for ABA were set at 10 MFI on the X axis, and at 0.01 kU/l for ISAC values on the Y axis. The
Spearman r correlation coefficient, the x
2 and the Fisher’s exact tests were used where applicable.
doi:10.1371/journal.pone.0035697.g004
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PLoS ONE | www.plosone.org 9 April 2012 | Volume 7 | Issue 4 | e35697Undoubtedly good results were obtained and the lack of a
reference curve seems not to affect the IgE detection between the
two distant runs at least in terms of positive/negative concordance.
The experiment could be of course be biased by the non random
selection of samples which has been performed on the basis of
serum sample availability.
Discussion
In the present study we report for the first time the feasibility of
a new multiplex system customized for detecting specific IgE
testing in serum, which uses allergenic molecules coupled with
micro-beads undergoing fluorescence measurement by the cytom-
eter available in our lab facilities. Starting from the coupling of the
allergens with the micro-beads to the overall extensive IgE testing
results, the aims of our study were fulfilled. Major achievements
were the almost overlapping results obtained when comparing
ABA to the control system and the suitability of the ABA IgE
testing system for all the allergenic molecules tested so far. The
cytometric ABA system herein described was not affected by
background noise frequently observed in other serum-based
immunoassays. This was clearly shown in several of our
experiments, mostly in the one using samples with very high total
IgE values. Furthermore, since we have not set a system negative
cut off using a reference curve, our arbitrary cut off worked almost
perfectly, with the exception of nDer s 1 where positive values
were quite often slightly above the cut off unless the comparative
ISAC IgE testing was negative. Since this behavior was not
influenced by the testing of hyper-IgE samples, we considered it
useful to evaluate again the quality of the preparation as it seemed
to have some critical points when used on the ABA assay rather
than on the ISAC microarray. Anyhow, creating a reference
standard curve, by using one of the currently available approaches,
will be a further step to qualify the ABA IgE testing system. The
results obtained in reproducibility experiment further reinforce the
idea that the ABA is a new suitable method to be used for IgE
detection.
Data analysis showed a very good linear correlation of IgE
detected by the flexible ABA system and the static ISAC
microarray, with good to excellent r values, though some allergens
showed a peculiar behavior. For instance, nPru p 3 tested on ISAC
showed 11 clear-cut positive results compared to the negatives
obtained by ABA testing. It is noteworthy that the two systems
bear two different nPru p 3 preparations. An explanation for the
discrepancy could be the different quality of purified molecules. In
this regard, the use of the same preparation, as in the study by
King et al. [16] to validate a new micro testing system, would
reduce the number of variables to be evaluated. In fact, they
developed a flexible multiplexed immunoassay for the detection of
specific IgE using the XMap technology (Luminex Corporation,
Austin, TX), which is based on a similar micro-bead system but
needing a proprietary laser scanner for the final fluorescence
estimation [16]. In the study, IgE results obtained using six
allergens coupled on the microspheres, namely nDer p 1, nDer p
2, rBet v 1, nFel d 1, nCan f 1, and rPhl p 5, were compared to
those obtained by testing using commercial ELISA plates (all six
allergens) and using the streptavidin-CAP (Phadia) testing (Der p 1
and Der p 2). The latter is the most common singleplex testing
system used worldwide for routine IgE measurements. For the
purpose of the study, ‘‘flexibility’’ of the system was obtained by
coupling the allergen on the ImmunoCAP solid phase using the
biotin-streptavidin methodology [25]. This approach allowed the
authors to use the same allergen preparations on the three testing
systems. Very good results were obtained although on few
allergens. Our results were almost comparable to those obtained
by Erwin et al. for almost all allergens, but we were forced to not
use the ImmunoCAP as a comparison, because not all molecules
we studied had a commercially available ImmunoCAP prepara-
tion, and the use of a customized streptavidin-CAP or an ELISA
assay would not be affordable in terms of allergenic molecule
preparation amounts and costs, whether produced by our lab or
purchased from commercial providers. Up to now no other reports
have been found in literature using the same system for IgE
detection, notwithstanding King et al. clearly showed the
possibility of using microtechnology and allergenic molecules for
IgE testing. As any other micro system - including our new ABA
test - the main feature of the latter is that it needs very small
amounts of any reagent. This holds true also when comparing the
micro-bead-based system with a customizable system like the
streptavidin-CAP, where larger amounts of allergen preparations
and reagents are required [25]. The alternative use of the
ImmunoCAP system based on currently available allergenic
extracts was not feasible as well, as any of its extract is composed
by known and unknown allergens resulting in a complex IgE
measurement, which could mislead the conclusions of our study.
Figure 5. ABA versus ISAC IgE correlation results on 1,519
serum samples selected on the basis of any of the allergen
specificities reported in Table S1, using the two micro systems.
Letter flag (A) in figure 5 indicates it as part of the results shown also in
figures 6, 7, and 8. Consecutive letters are used on purpose to recall
result type continuity across the four figures. Allergen nature, being
either natural or recombinant, matched for both tests. Vertical dashed
lines represent the arbitrary ABA negative cut off value. Horizontal
dashed lines mark the value range where ISAC IgE determinations are
not always reproducible (unpublished data). For graphical visualization
needs on log scales, zero values for ABA were set at 10 MFI on the X
axis, and at 0.01 kU/l for ISAC values on the Y axis. The Spearman r
correlation coefficient was calculated and the x
2 test was used for
statistical purposes. Statistical results are reported below the graph.
doi:10.1371/journal.pone.0035697.g005
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PLoS ONE | www.plosone.org 10 April 2012 | Volume 7 | Issue 4 | e35697Figure 6. ABA versus ISAC correlation results on serum samples selected on the basis of the allergen specificities reported in each
panel and listed in Table S1. Letter flags, namely B, C, D, E, F, G, in figure 6 indicate them as parts of the results shown also in figures 5, 7, and 8.
Consecutive letters are used on purpose to recall result type continuity across the four figures. Allergen nature, being either natural or recombinant,
matched for both tests. Vertical dashed lines represent the arbitrary ABA negative cut off value. Horizontal dashed lines mark the value range where
ISAC IgE determinations are not always reproducible (unpublished data). For graphical visualization needs on log scales, zero value for ABA was set at
10 MFI on the X axis, and at 0.01 kU/l for ISAC value on the Y axis. The Spearman r correlation coefficient was calculated and the Fisher’s exact test
was used for statistical purposes. Statistical results are reported below each graph.
doi:10.1371/journal.pone.0035697.g006
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PLoS ONE | www.plosone.org 11 April 2012 | Volume 7 | Issue 4 | e35697Figure 7. ABA versus ISAC correlation results on serum samples selected on the basis of the allergen specificities reported in each
panel and listed in Table S1. Letter flags, namely H, I, J, K, L, M, in figure 7 indicate them as parts of the results shown also in figures 5, 6, and 8.
Consecutive letters are used on purpose to recall result type continuity across the four figures. Allergen nature, being either natural or recombinant,
matched for both tests. Vertical dashed lines represent the arbitrary ABA negative cut off value. Horizontal dashed lines mark the value range where
ISAC IgE determinations are not always reproducible (unpublished data). For graphical visualization needs on log scales, zero value for ABA was set at
10 MFI on the X axis, and at 0.01 kU/l for ISAC value on the Y axis. The Spearman r correlation coefficient was calculated and the Fisher’s exact test
was used for statistical purposes. Statistical results are reported below each graph.
doi:10.1371/journal.pone.0035697.g007
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PLoS ONE | www.plosone.org 12 April 2012 | Volume 7 | Issue 4 | e35697A different kind of microtechnology for IgE testing, first
reported by Hiller and co-workers [6], is currently used worldwide
and many studies have been published based on its use [26]. The
ISAC test is based on allergenic molecules immobilized in a fixed
number and kind on an activated glass slide [9]. This was basically
the robustness of the study we recently published, where 23,077
subjects from the routine setting were all tested using the same
panel of 75 molecules. The current version of the ISAC test (PMD)
bears 103 natural and recombinant molecules. The ISAC testing
system has been used in our lab for five years now and its routine
use, inclusive of its ‘‘rigid’’ structure, allowed us to generate a
wealth of research data comparing intervention cohorts and
control cohorts, all within routine testing without much additional
effort and resources [7,20,24,27,28]. Since this aspect can be
envisaged as useful for the routine diagnostic workup and a
combined well-structured epidemiological survey of different
populations, the need of having the same advantages of
microtechnology combined with a greater flexibility of the system
was felt, for instance, when enrolling infants and newborns for
studying limited aspects of their IgE reactivity, or when
performing studies on allergens not yet available on the ISAC
microarray or in any other system [18]. Thus the flexibility of the
new ABA system could represent a major advantage if it allows
choosing a personalized panel of allergens to test. As said, allergen-
specific IgE measurement carried out simultaneously in a single
run using the FACS facilities increases the chance of having a
configurable microarray system for IgE measurements in depart-
ment laboratories. Besides the flexibility in the panel of molecules
to be used, the small amount of serum needed for the ABA test
(50 ml), whatever the number of micro-beads/allergens to be
tested, represents another key feature, as its use is possible when
only scant amounts of biological fluids are available, such as in
pediatric patient evaluation.
Compared to the ISAC microarray, the new ABA IgE assay has a
limitation in the number of micro-beads that can be theoretically
conjugated and analyzed at once. Thirty different micro-beads are
Figure 8. ABA versus ISAC correlation results on serum samples selected on the basis of the allergen specificities reported in each
panel and listed in Table S1. Letter flags, namely N, O, P, Q, in figure 8 indicate them as parts of the results shown also in figures 5, 6, and 7.
Consecutive letters are used on purpose to recall result type continuity across the four figures. Allergen nature, being either natural or recombinant,
matched for both tests. Vertical dashed lines represent the arbitrary ABA negative cut off value. Horizontal dashed lines mark the value range where
ISAC IgE determinations are not always reproducible (unpublished data). For graphical visualization needs on log scales, zero value for ABA was set at
10 MFI on the X axis, and at 0.01 kU/l for ISAC value on the Y axis. The Spearman r correlation coefficient was calculated and the Fisher’s exact test
was used for statistical purposes. Statistical results are reported below each graph.
doi:10.1371/journal.pone.0035697.g008
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PLoS ONE | www.plosone.org 13 April 2012 | Volume 7 | Issue 4 | e35697Figure 9. Selected examples of Allergen micro-Beads Array (ABA) IgE testing report. Eleven different micro-beads were tested in the same
tube in each run for each sample. Examples were selected on purpose among the samples with high total IgE. All IgE positive and negative ABA
results matched the ISAC results. Numbers in the upper left corner indicate the Table S1 row numbers and patients’ ID. In each panel: the upper left
graph shows clustered micro-beads by their dimension; the upper right: scatter plots of each fluorescent bead; the lower left: fluorescence intensity
and event counts; the lower right: summary table with median fluorescence values. Samples reported in each of the six panels had the following total
IgE values: Panel A=9,730 IU/l; Panel B=1,351 IU/l; Panel C=1,220 IU/l; Panel D=1,931 IU/l; Panel E=20,900 IU/l; Panel F=23,540 IU/l.
doi:10.1371/journal.pone.0035697.g009
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PLoS ONE | www.plosone.org 14 April 2012 | Volume 7 | Issue 4 | e35697currently available being quite far from the numbers of the ‘‘rigid’’
ISAC microarray, which have evolved from the early 74 to the
current 103 immobilized allergens, without apparent expansion
limitations. The practical aspect of ABA assay limitations is related
to the number of combinations that should be obtained to have a
largernumberofdifferentfluorescenceoneach micro-bead,and the
problematic discrimination of micro-beads having the fluorescence
cluster too close to one another. This aspect intuitively emerged
from the ABA IgE testing reports shown in Figure 9, where the
emission fluorescence proximity of each micro-bead avoided them
from overlapping because we purposely used micro-beads that were
not too close one another. The use of the nearest micro-bead led to
anoverlappingofthetwoclosestbead fluorescenceemissions.These
technical limitations could hinder the expansion of the ABA system
allowing a broad IgE testing for routine allergy diagnosis.
Nevertheless, as shown in Table S1, the IgE co-recognition of nAct
d 11, rAln g 1, rBet v 1, rCor a 1, structurally related allergens
belonging to the same Bet v 1-like family, and, with more limited
evidence, by nArt v 3 and nPru p 3, both belonging to the LTP
family, suggests that the ABA assay is useful for studying IgE cluster
reactivityonhomologousmolecules,as recentlyreported byScalaet
al. [7] and described in more in detail in a recently accepted
manuscript [29]. Moreover, testing allergens from species very close
to one another, as in the case of nDer p 1 and nDer s 1, allows the
comparative evaluation of the preparations, addressing the need of
increasing the quality to improve performance in the diagnostic test.
Since we used mouse monoclonal and rabbit polyclonal
antibodies in our study, employment of the ABA system to detect
different human and non-human immunoglobulin isotypes in
response to different allergens/antigens can be foreseen, thus
facilitating larger experimental outcomes, mostly when using
small-sized experimental animals.
In conclusion, we report the proof-of-concept that a quite
simple flow cytometry micro-bead-based multiplex antigen array
technology is suitable for the simultaneous detection of allergen-
specific human IgE in not highly specialized laboratories with
FACS facilities.
Supporting Information
Figure S1 Allergen micro-Bead Array (ABA) dilution
curves of selected non-human sera. All dilution curves
started with the undiluted antibody preparation as provided by the
manufacturer. Panel A: nDer s 1 and monoclonal antibody from
Biocen 4E10E10; 1:10 dilution factor; Panel B: nPen m 1 and the
polyclonal antibody from BIAL; 1:2 dilution factor; Panel C: nPen
m 1 and the polyclonal antibody from ALK-Abello ´; 1:10 dilution
factor.
(TIF)
Figure S2 Allergen micro-Bead Array (ABA) reproduc-
ibility experiment on non-randomized sera. Sera have
been selected among those reported in Table S1 and on the basis
of their availability for a further testing. 283 IgE determinations
have been performed on sera from 114 subjects and 15 allergens
but Act d 1 have been used. For graphical visualization needs on
log scales, zero values for ABA were set at 10 MFI on both axes.
The Spearman r correlation coefficient was equal to 0.91 (95% CI
0.88–0.93; p,0.001). The Fisher’s exact test for contingency data
table gave a concordance p value,0.0001 as only 17 discrepant
results were recorded.
(TIF)
Table S1 Allergen micro-Bead Array (ABA) for IgE
detection in human sera. Aggregated and raw patient
IgE data showing the flexibility of the system. The 16
tested allergens are listed and hyperlinks are available for each of
them cross-referencing to www.allergome.org. Panel A: Summary
of the Table S1 patients’ demographics and ABA IgE results. a: All
tests performed for the given allergen (first row), positive tests
(second row), median test value (third row); b: Positive tests
(MFI.200; green background cells): lowest value (first row),
highest value (second row), median value (third row); c: Negative
tests (MFI,200; grey background cells): lowest value (first row),
highest value (second row), median value (third row). Panel B: Raw
IgE values for every single subject ranked by age are expressed as
Median Fluorescence Intensity [MFI]. Green and grey cell
background meaning throughout the table is as in Panel A
sections (b) and (c). Selected examples of ABA IgE testing reports
are shown in Figure 9. Subjects ID are marked with a blue
background in this Table.
(XLS)
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